Research 06.08.2026
Invesco QQQ Trust Series I BATS:QQQ
🌏Markets:
- 08:30 USA – Initial/Continuing Jobless Claims
- 08:30 USA – Nonfarm Productivity
- 08:30 USA – Unit Labour Costs
Reaction to earnings/guidance:
-
SOUN
DASH
CEG
USFD
IONQ
LNG
HWM
OXY
MCK
CNQ
TRGP $O
COP $
SITM
INSM
CAI
LFST
PAYC
RXO
ATI
MSI
PH $U
IOVA
RDW
MGNI
MTSI
DEO
HIMX
OSCR
CHYM
IONQ
ALB
GENI
COP
MCK
-
CLRO Cancels 437,500 First Finance Warrants at $5.00 Amid Cortigent Merger Process
-
WYHG : no-news, low-float ADR pump
-
PAVS
: SEC filing confirming Paranovus closed its acquisition of the athletic wear brand Heyviva from Jabanero Inc.
-
WPP : Sequential improvement, strong new business, and cost discipline set up a 2027 growth return
-
MRNA secures FDA approval for its first mRNA influenza vaccine
-
LIME surprised investors with firts earnings report after IPO.
-
LYY raises 2026 outlook again as Q2 soars past estimates
- Space Stocks Are Roaring Back In August :
ASTS
RKLB
RDW
Reaction to earnings/guidance:
-
SNDK
HUBS
DDOG
APP
CELH
WDC
FOUR HONA
FIG
PTON
BLLN
MIRM
FLNC
RUN
KVYO
EPAM
VISN
BROS
QBTS
FISV
SNDK
DUOL
NVMI
ZTS
AXON
UWMC
CELH
-
YXT
: Nasdaq Minimum Bid Price Requirement Compliance pump&dump.
- Memory stocks falls in syphaty to
WDC
SNDK reports:
SKHY
CLS
MU
- DeepSeek Plans ‘Significant’ Price Increase for Its AI Services, an unusual shift from the Chinese tech sector that has put pressure on US competitors with its aggressive pricing.
BIDU
BABA
NVDA
-
CRWV Signs Multi-Year Agreement With Solidigm to Strengthen Its Integrated AI Cloud Platform
- China has launched a cybersecurity review of products sold in the country by U.S. company Palo Alto Networks
PANW , citing risks to critical information infrastructure and national security, the country's cyberspace regulator said on Thursday.
-
SPCX share lockup ends today, and it could trigger more selling (insiders and early investors will be able to sell their stock for the first time on Thursday, when 911.5 million shares become eligible to trade — around 43% more than the 638.9 million shares the company floated in its June initial public offering.)
-
UBER has received its first license to launch driverless taxis in London.
- Bezos sold Amazon
AMZN shares again, this time worth $346.5 million.
- Daily trading volume in S&P 500 call options hit a new record.
-- US Treasuries came under selling pressure after the FT reported that Warsh is prepared to raise rates at the September meeting if inflation data released in the coming weeks remains elevated.
-- The percentage of S&P 500 stocks outperforming the index this year has risen to a 10-year high.
-
BRVE
– Braveheart Bio
Company develops treatments for hypertrophic cardiomyopathy, a serious heart disease where the heart muscle becomes abnormally thick and does not relax properly. Lead candidate BHB-1893 was licensed from Hengrui and is planned for global Phase 3 trials in both obstructive and non-obstructive HCM. Core thesis is a late-stage cardiovascular drug targeting a large market with high unmet medical need.
- Price: $18.00
- Shares: 21.3M
- Raised: $382.5M
- Market Cap: ~$1.32B
LTM:
- Revenue: $0
- Net Income: -$80.2M
Key point:
- IPO was upsized and priced above the original range, while clinical data so far came mostly from Hengrui-run trials in China.
- Comparable public companies:
CYTK ,
BMY , KARD ,
ALNY ,
IONS ,
VERV
Best regards – hi2morrow team.